Asia Pacific Blood Irradiation Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type (Intravenous Laser Blood Irradiation, Transcutaneous Laser Blood Irradiation, and Extracorporeal Blood Irradiation), Indication (Acute Leukemia, Lymphoma, Solid Tumors, Pelvic Tumors, and Others), and End User (Hospitals, Blood Banks, Diagnostics Clinics, and Research Institutes)   

No. of Pages: 114    |    Report Code: BMIRE00027194    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Blood Irradiation Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Asia Pacific Blood Irradiation Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Asia Pacific Blood Irradiation Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing use of blood transfusions
  • 5.1.2 Rising prevalence of blood-borne diseases
5.2 Market Opportunities
  • 5.2.1 Growth in healthcare and hospital applications
  • 5.2.2 Expansion in emerging healthcare markets
5.3 Future Trends
  • 5.3.1 Development of more efficient and portable blood irradiation devices
  • 5.3.2 Integration with blood safety protocols
5.4 Impact of Drivers and Restraints

6. Asia Pacific Blood Irradiation Market Regional Analysis

6.1 Asia Pacific Blood Irradiation Market Overview
6.2 Asia Pacific Blood Irradiation Market Revenue 2020-2028 (US$ Million)
6.3 Asia Pacific Blood Irradiation Market Forecast Analysis

7. Asia Pacific Blood Irradiation Market Analysis – by Type

7.1 Intravenous Laser Blood Irradiation
  • 7.1.1 Overview
  • 7.1.2 Intravenous Laser Blood Irradiation: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Transcutaneous Laser Blood Irradiation
  • 7.2.1 Overview
  • 7.2.2 Transcutaneous Laser Blood Irradiation: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Extracorporeal Blood Irradiation
  • 7.3.1 Overview
  • 7.3.2 Extracorporeal Blood Irradiation: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Blood Irradiation Market Analysis – by Indication

8.1 Acute Leukemia
  • 8.1.1 Overview
  • 8.1.2 Acute Leukemia: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Lymphoma
  • 8.2.1 Overview
  • 8.2.2 Lymphoma: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Solid Tumors
  • 8.3.1 Overview
  • 8.3.2 Solid Tumors: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Pelvic Tumors
  • 8.4.1 Overview
  • 8.4.2 Pelvic Tumors: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Blood Irradiation Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Pelvic Tumors: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Blood Banks
  • 9.2.1 Overview
  • 9.2.2 Pelvic Tumors: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Diagnostics Clinics
  • 9.3.1 Overview
  • 9.3.2 Pelvic Tumors: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Research Institutes
  • 9.4.1 Overview
  • 9.4.2 Pelvic Tumors: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Blood Irradiation Market – Asia-Pacific Analysis

10.1 Asia-Pacific
  • 10.1.1 Asia Pacific Blood Irradiation Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 Asia Pacific Blood Irradiation Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 China: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 China: Asia Pacific Blood Irradiation Market Breakdown, by Type
    • 10.1.1.1.2 China: Asia Pacific Blood Irradiation Market Breakdown, by Indication
    • 10.1.1.1.3 China: Asia Pacific Blood Irradiation Market Breakdown, by End User
  • 10.1.1.2 India: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 India: Asia Pacific Blood Irradiation Market Breakdown, by Type
    • 10.1.1.2.2 India: Asia Pacific Blood Irradiation Market Breakdown, by Indication
    • 10.1.1.2.3 India: Asia Pacific Blood Irradiation Market Breakdown, by End User
  • 10.1.1.3 Japan: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Japan: Asia Pacific Blood Irradiation Market Breakdown, by Type
    • 10.1.1.3.2 Japan: Asia Pacific Blood Irradiation Market Breakdown, by Indication
    • 10.1.1.3.3 Japan: Asia Pacific Blood Irradiation Market Breakdown, by End User
  • 10.1.1.4 Australia: Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Australia: Asia Pacific Blood Irradiation Market Breakdown, by Type
    • 10.1.1.4.2 Australia: Asia Pacific Blood Irradiation Market Breakdown, by Indication
    • 10.1.1.4.3 Australia: Asia Pacific Blood Irradiation Market Breakdown, by End User
  • 10.1.1.5 Rest of Asia-Pacific : Asia Pacific Blood Irradiation Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Blood Irradiation Market Breakdown, by Type
    • 10.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Blood Irradiation Market Breakdown, by Indication
    • 10.1.1.5.3 Rest of Asia-Pacific : Asia Pacific Blood Irradiation Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Asia Pacific Blood Irradiation Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Hitachi, Ltd.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Best Theratronics Ltd.,
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Gilardoni S.p.A.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Typenex Medical
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Actemium
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - A Market

  1. Hitachi, Ltd.                                       
  2. Best Theratronics Ltd.,                                  
  3. Gilardoni S.p.A.                                                
  4. Typenex Medical 
  5.     Actemium          
asia-pacific-blood-irradiation-market